27.11.2012 Views

BioWorld® - Medical Device Daily

BioWorld® - Medical Device Daily

BioWorld® - Medical Device Daily

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Recordati SpA<br />

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information<br />

Via M. Civitali, 1<br />

Milan 20148, Italy<br />

Phone: +39 2-487871; Fax: +39 2-40073747<br />

Web: www.recordati.com; E-mail: inver@recordati.it<br />

KEY PERSONNEL: Giovanni Recordati; Chairman and CEO<br />

Walter Bevilacqua; VP and Director, Corporate Development<br />

Giorgio Oberrauch; VP and GM, Pharmaceutical Chemicals<br />

Abraham Sartani; VP and Director, Pharmaceutical R&D Division<br />

Fritz Squindo; CFO<br />

Franco TomasniI; VP and Director, Purchasing and Logistics<br />

EMPLOYEES: 2,000+ employees<br />

HISTORY: Founded in 1926<br />

Acquired Merckle GmbH's branded pharmaceutical business (2/05)<br />

To acquire Jaba Farmaceutica (as of 7/06)<br />

STOCK-FINANCIAL HISTORY: Italian Stock Exchange--(Reuters REC.MI) (Bloomberg REC IM) (ISIN IT<br />

003074447)<br />

IPO--1984<br />

Revenue EUR576.1M (YE 05) compared to EUR479.2M (YE 04)<br />

Net income EUR64.5M (YE 05) compared to EUR53.1M (YE 04)<br />

PRIVATE PLACEMENTS: Raised $100M in private placement (10/04)<br />

SUBSIDIARIES/DIVISIONS: Recordati SA--Luxembourg<br />

Innova Pharma SpA--Italy<br />

Bouchara Recordati SAS--France<br />

Recodati Hellas Pharmaceuticals SA--Greece<br />

Recordati Corp.--U.S.<br />

Recordati SA--Switzerland<br />

Recordati Espana SL--Spain<br />

Merckle Recordati GmbH--Germany<br />

Recordati Ireland Ltd.<br />

Recordati Pharmaceuticals Ltd.--U.K.<br />

AGREEMENTS: Name Products Content of Agreement Date<br />

Allergan Imidazyl, Herbe distribution<br />

agreement<br />

1994<br />

Angelini prulifloxacin non-exclusive<br />

licensing agreement<br />

9/04<br />

ASINEX Ltd. micturition disorders drug discovery<br />

collaboration<br />

10/04<br />

BYK Gulden Peptazol (pantoprazole) non-exclusive<br />

licensing agreement<br />

1/02<br />

Dexcel Ltd. oral formulation of exclusive liensing 10/02<br />

cyclosporin<br />

agreement<br />

Digital Gene Digital's gene<br />

licensing<br />

4/97<br />

Technologies Inc. expression technology agreement--Digital<br />

and Recordati's calcium received $3M up<br />

channel blocker front and could<br />

(Lercanidipine) against receive milestone<br />

atherosclerosis<br />

payments and<br />

royalties<br />

Eurand<br />

modified-release development 9/04<br />

International SpA formulation of<br />

lercanidipine (Zanidip)<br />

agreement<br />

Grupo Uriach rupatadine licensing agreement 9/04<br />

InfaCare<br />

development and exclusive licensing 6/05<br />

Pharmaceutical marketing of Stanate agreement<br />

Corp.<br />

(stannsoporfin)<br />

Kissei<br />

Pharmaceutical<br />

Co. Ltd.<br />

silodosin licensing agreement 10/04<br />

Copyright ©2006 AHC Media ® 337

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!